1
|
Diep AN, Schyns J, Gourzones C, Goffin E, Papadopoulos I, Moges S, Minner F, Ek O, Bonhomme G, Paridans M, Gillain N, Husson E, Garigliany M, Darcis G, Saegerman C, Desmecht D, Guillaume M, A F D, Bureau F, Gillet L. How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity dynamics: An 18-month longitudinal study. J Infect 2024; 88:183-186. [PMID: 37981216 DOI: 10.1016/j.jinf.2023.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Accepted: 11/15/2023] [Indexed: 11/21/2023]
Affiliation(s)
- A N Diep
- Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium
| | - J Schyns
- Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, 4000 Liège, Belgium; COVID-19 Platform, Liège University, 4000 Liège, Belgium
| | - C Gourzones
- COVID-19 Platform, Liège University, 4000 Liège, Belgium; Laboratory of Immunology-Vaccinology, FARAH, Liège University, 4000 Liège, Belgium
| | - E Goffin
- COVID-19 Platform, Liège University, 4000 Liège, Belgium; Laboratory of Immunology-Vaccinology, FARAH, Liège University, 4000 Liège, Belgium
| | - I Papadopoulos
- Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium
| | - S Moges
- Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium
| | - F Minner
- COVID-19 Platform, Liège University, 4000 Liège, Belgium
| | - O Ek
- COVID-19 Platform, Liège University, 4000 Liège, Belgium
| | - G Bonhomme
- Department of Pathology, FARAH, Liège University, 4000 Liège, Belgium
| | - M Paridans
- From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium
| | - N Gillain
- Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium; From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium
| | - E Husson
- Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium; From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium
| | - M Garigliany
- Department of Pathology, FARAH, Liège University, 4000 Liège, Belgium
| | - G Darcis
- Infectious Diseases Department, University Hospital of Liège, 4000 Liège, Belgium
| | - C Saegerman
- Research Unit in Epidemiology and Risk Analysis applied to Veterinary Sciences, FARAH, Liège University, 4000 Liège, Belgium
| | - D Desmecht
- Department of Pathology, FARAH, Liège University, 4000 Liège, Belgium
| | - M Guillaume
- From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium
| | - Donneau A F
- Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium
| | - F Bureau
- Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, 4000 Liège, Belgium; COVID-19 Platform, Liège University, 4000 Liège, Belgium
| | - L Gillet
- COVID-19 Platform, Liège University, 4000 Liège, Belgium; Laboratory of Immunology-Vaccinology, FARAH, Liège University, 4000 Liège, Belgium.
| |
Collapse
|
2
|
Yang Y, Gong X, Tang Y, Liu J, Zeng L, Kuang J, Wang F, Lu H, Liu Y. Naive and breakthrough infections with BA.2, BA.5 and BF.7 variants provide poor cross protection against XBB related variants. J Infect 2023:S0163-4453(23)00299-2. [PMID: 37245543 DOI: 10.1016/j.jinf.2023.05.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Accepted: 05/24/2023] [Indexed: 05/30/2023]
Affiliation(s)
- Yang Yang
- Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
| | - Xiaohua Gong
- Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China
| | - Yimin Tang
- Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China
| | - Jiexiang Liu
- Guangzhou University of Traditional Chinese Medicine
| | - Lijiao Zeng
- Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China
| | - Jiahua Kuang
- Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China
| | - Fuxiang Wang
- Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
| | - Hongzhou Lu
- Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
| | - Yingxia Liu
- Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
| |
Collapse
|
3
|
Gu F, Lin H, Chen Z, Ambler G, Chen X, Chen X, Xia P, Liu N, Du H. Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study. Vaccines (Basel) 2023; 11:vaccines11050987. [PMID: 37243091 DOI: 10.3390/vaccines11050987] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/06/2023] [Accepted: 05/11/2023] [Indexed: 05/28/2023] Open
Abstract
Background: An unprecedented coronavirus disease 2019 (COVID-19) wave occurred in China between December 2022 and January 2023, challenging the efficacy of the primary series of COVID-19 vaccines. The attitudes toward future COVID-19 booster vaccines (CBV) after the massive breakthrough infection among healthcare workers remain unknown. This study aimed to explore the prevalence and determinants of future CBV refusal after the unprecedented COVID-19 wave among healthcare workers. Methods: Between 9 and 19 February 2023, a cross-sectional nationwide online survey was conducted using a self-administered questionnaire vaccine among healthcare workers in China. Sociodemographics, profession, presence of chronic medical conditions, previous COVID-19 infection, attitudes towards future CBV, and reasons for future CBV refusal were collected. We estimated odds ratio [OR] with 95% confidence interval [CI] using a multivariable logistic regression model to explore the factors associated with future CBV refusal. Results: Among the 1618 participants who completed the survey, 1511 respondents with two or more doses of COVID-19 vaccines were analyzed. A total of 648 (41.8%) of respondents were unwilling to receive a future CBV. Multivariable logistic regression analysis revealed the association of CBV refusal with profession (vs. other staff, physician-adjusted OR 1.17, 95%CI 0.79-1.72, nurse-adjusted OR 1.88, 95%CI 1.24-2.85, p = 0.008), history of allergy (adjusted OR 1.72, 95%CI 1.05-2.83, p = 0.032), a lower self-perceived risk of future COVID-19 infection (p < 0.001), and a lower belief in CBV effectiveness (p = 0.014), safety (p < 0.001), and necessities for healthcare workers and the public (p < 0.001, respectively). Conclusions: Our findings highlight that a considerable proportion of healthcare workers were against a future booster dose after an unprecedented COVID-19 wave. Self-perception of future COVID-19 risk, and potential harm or doubtful efficacy of vaccines are the main determinants. Our findings may help public health authorities to establish future COVID-19 vaccination programs.
Collapse
Affiliation(s)
- Fuying Gu
- Department of Hepatobiliary Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225012, China
| | - Huiying Lin
- Department of Neurology, Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - Zhenqiang Chen
- Department of Rehabilitation, Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - Gareth Ambler
- Statistical Science, University College London, London WC1E 6BT, UK
| | - Xinyan Chen
- Statistical Science, University College London, London WC1E 6BT, UK
| | - Xiaoling Chen
- Department of Infectious Disease, Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - Pincang Xia
- Fujian Center for Disease Control and Prevention, Fuzhou 350001, China
| | - Nan Liu
- Department of Neurology, Fujian Medical University Union Hospital, Fuzhou 350001, China
- Department of Rehabilitation, Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - Houwei Du
- Department of Neurology, Fujian Medical University Union Hospital, Fuzhou 350001, China
- Department of Rehabilitation, Fujian Medical University Union Hospital, Fuzhou 350001, China
| |
Collapse
|
4
|
Wang J, Dong H, Zhao J, Li T, Wang M, Zhou C, Mu H. Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study. Front Microbiol 2023; 14:1096022. [PMID: 37065120 PMCID: PMC10101175 DOI: 10.3389/fmicb.2023.1096022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Accepted: 03/13/2023] [Indexed: 04/03/2023] Open
Abstract
IntroductionThe protective effect of SARS-CoV-2 vaccines has become a global focus due to Omicron variant pandemic. The effects of various SARS-CoV-2 vaccines are diverse. However, studies on the effect of domestic vaccines on clinical characteristics in convalescent adult patients infected with the Omicron variant are lacking.MethodsIn this retrospective, single-center cohort study, the effect of three domestic vaccines on clinical characteristics of convalescent adult patients infected with the Omicron variant was investigated in the initial largest outbreak of the Omicron variant infection between January and February 2022 in Tianjin, China. The primary endpoint was COVID-19 severity and the secondary endpoints were re-positive results on nucleic acid tests, liver and kidney function, and inflammation levels during recovery.ResultsA total of 320 adult patients infected with the Omicron variant were enrolled, including 296 post-vaccination and 24 unvaccinated patients. The median age of the unvaccinated patients was higher than that of vaccinated patients, but no significant difference was detected in the sex composition ratio between the different groups. Binary logistic regression results suggested that Sinopharm and Sinovac vaccine was an independent protective factor for relieving the severity of the Omicron variant infection. Regrettably, the vaccines did not showed any protective effect on the liver and kidney function of convalescent adult patients. Three domestic vaccines significantly relieved inflammation and increased the SARS-CoV-2-specific antibody levels. Furthermore, Sinovac and CanSino vaccines had a better immune stimulation effect on increasing T lymphocytes levels in convalescent adult patients. In addition, three domestic vaccines have protective effects on preventing re-detectable positive (RP) result in convalescent adult patients.ConclusionAlthough the three domestic vaccines cannot prevent the infection of the Omicron variant, it has a significant protective effect in adult patients. This study supports the policy of accelerating to vaccination worldwide combat the evolving and mutating SARS-CoV-2.DiscussionOmicron spreads faster and might escape antibodies more readily than previous variants, increasing the cases of reinfection and breakthrough infections in vaccinated people. Although vaccinated people are likely to have a much lower risk of severe disease from Omicron infection, many issues still need to be considered. Concerns about lower vaccine efficacy because of new variants might have changed our understanding of the COVID-19 endgame, disabusing the world of the notion that global vaccination is by itself adequate for controlling SARS-CoV-2 infection. The current data showed that vaccination with three domestic SARS-CoV-2 vaccines alleviates the disease severity of adult patients with COVID-19, reduces the inflammation level and the RP rate of convalescent adult patients, and enhances body’s defense against the virus in convalescent adult patients. Moreover, our study has highlighted that a combination prevention approach of vaccination and public health measures would be an effective strategy.
Collapse
Affiliation(s)
- Jingyu Wang
- Department of Laboratory Medicine, Tianjin First Central Hospital, Tianjin, China
| | - Henan Dong
- The First Central Clinical School, Tianjin Medical University, Tianjin, China
| | - Jie Zhao
- Department of Laboratory Medicine, Tianjin First Central Hospital, Tianjin, China
| | - Tianning Li
- Department of Laboratory Medicine, Tianjin First Central Hospital, Tianjin, China
| | - Meng Wang
- Department of Laboratory Medicine, Tianjin First Central Hospital, Tianjin, China
| | - Chunlei Zhou
- Department of Laboratory Medicine, Tianjin First Central Hospital, Tianjin, China
- *Correspondence: Chunlei Zhou,
| | - Hong Mu
- Department of Laboratory Medicine, Tianjin First Central Hospital, Tianjin, China
- *Correspondence: Chunlei Zhou,
| |
Collapse
|
5
|
Mohapatra RK, Verma S, Kandi V, Sarangi AK, Seidel V, Das SN, Behera A, Tuli HS, Sharma AK, Dhama K. The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review. ChemistrySelect 2023. [DOI: 10.1002/slct.202201380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/05/2023]
Affiliation(s)
- Ranjan K. Mohapatra
- Department of Chemistry Government College of Engineering Keonjhar 758002 Odisha India
| | - Sarika Verma
- Council of Scientific and Industrial Research-Advanced Materials and Processes Research Institute Bhopal MP 462026 India
- Academy of council Scientific and Industrial Research - Advanced Materials and Processes Research Institute (AMPRI) Hoshangabad Road Bhopal (M.P) 462026 India
| | - Venkataramana Kandi
- Department of Microbiology Prathima Institute of Medical Sciences Karimnagar 505417 Telangana India
| | - Ashish K. Sarangi
- Department of Chemistry School of Applied Sciences Centurion University of Technology and Management Odisha India
| | - Veronique Seidel
- Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow G4 0RE United Kingdom
| | - Subrata Narayan Das
- Department of Mining Engineering Government College of Engineering Keonjhar 758002 Odisha India
| | - Ajit Behera
- Department of Metallurgical & Materials Engineering National Institute of Technology Rourkela 769008 India
| | - Hardeep Singh Tuli
- Department of Biotechnology Maharishi MarkandeshwarEngineering College Maharishi MarkandeshwarDeemed to be University, Mullana Ambala, 133207 Haryana India
| | - Ashwani K. Sharma
- Department of Chemistry Government Digvijay (Autonomous) Post-Graduate College Rajnandgaon (C.G. India
| | - Kuldeep Dhama
- Division of Pathology ICAR-Indian Veterinary Research Institute Bareilly
| |
Collapse
|
6
|
Wang JY, Li TN, Zhou CL, Zhao J, Wang M, Wang Y, Jiang Y, Dong HN, Qi QR, Mu H. Clinical and immunological features of convalescent pediatric patients infected with the SARS-CoV-2 Omicron variant in Tianjin, China. Virol Sin 2022; 37:850-859. [PMID: 36328182 PMCID: PMC9621613 DOI: 10.1016/j.virs.2022.10.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2022] [Accepted: 10/27/2022] [Indexed: 11/06/2022] Open
Abstract
COVID-19 has spread surprisingly fast worldwide, and new variants continue to emerge. Recently, the World Health Organization acknowledged a new mutant strain "Omicron", with children were accounting for a growing share of COVID-19 cases compared with other mutant strains. However, the clinical and immunological characteristics of convalescent pediatric patients after Omicron infection were lacking. In this study, we comparatively analyzed the clinical data from pediatric patients with adult patients or healthy children and the effects of SARS-CoV-2 vaccine on the clinical and immune characteristics in convalescent pediatric patients. Our results indicated that convalescent pediatric patients had unique clinical and immune characteristics different from those of adult patients or healthy children, and SARS-CoV-2 vaccination significantly affected on the clinical and immune characteristics and the prevention of nucleic acid re-detectable positive (RP) in convalescent patients. Our study further deepens the understanding of the impact of Omicron on the long-term health of pediatric patients and provides a valuable reference for the prevention and treatment of children infected with Omicron.
Collapse
Affiliation(s)
- Jing-Yu Wang
- Department of Clinical Lab, Tianjin First Central Hospital, Tianjin, 300192, China
| | - Tian-Ning Li
- Department of Clinical Lab, Tianjin First Central Hospital, Tianjin, 300192, China
| | - Chun-Lei Zhou
- Department of Clinical Lab, Tianjin First Central Hospital, Tianjin, 300192, China
| | - Jie Zhao
- Department of Clinical Lab, Tianjin First Central Hospital, Tianjin, 300192, China
| | - Meng Wang
- Department of Clinical Lab, Tianjin First Central Hospital, Tianjin, 300192, China
| | - Yuan Wang
- Department of Clinical Lab, Tianjin First Central Hospital, Tianjin, 300192, China
| | - Yan Jiang
- Department of Clinical Lab, Tianjin First Central Hospital, Tianjin, 300192, China
| | - He-Nan Dong
- The First Central Clinical College, Tianjin Medical University, Tianjin, 300192, China
| | - Qian-Ru Qi
- Department of Clinical Lab, Tianjin Children's Hospital, Tianjin, 300074, China
| | - Hong Mu
- Department of Clinical Lab, Tianjin First Central Hospital, Tianjin, 300192, China,Corresponding author
| |
Collapse
|